US 7655758
Stable liquid IL-1 antagonist formulations
granted A61KA61K38/1793A61K38/2006
Quick answer
US patent 7655758 (Stable liquid IL-1 antagonist formulations) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K38/1793, A61K38/2006, A61K47/183, A61K47/26